Immune thrombocytopenic purpura – current management practices

Author： Sandler S Gerald   Tutuncuoglu S Osman  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.5, Iss.12, 2004-12, pp. : 2515-2527

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment of Immune Thrombocytopenic Purpura in Children: Current Concepts

By Shad Aziza T.  

Pediatric Drugs, Vol. 7, Iss. 5, 2005-01 ,pp. : 325-336

Adis International

Access to resources Recommend Favorite

Refractory Idiopathic Immune Thrombocytopenic Purpura in Children: Current and Future Treatment Options

By Imbach P.  

Pediatric Drugs, Vol. 5, Iss. 12, 2003-01 ,pp. : 795-801

Adis International

Access to resources Recommend Favorite

Management of Immune Thrombocytopenic Purpura in Children: Potential Role of Novel Agents

By >  

Pediatric Drugs, Vol. 13, Iss. 4, 2011-08 ,pp. : 213-223

Adis International

Access to resources Recommend Favorite

Dexamethasone effective in immune thrombocytopenic purpura

By  

Inpharma, Vol. 1, Iss. 1403, 2003-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Plasma Thrombospondin in Immune Thrombocytopenic Purpura

By Özcebe Oİ   Karakuş S   Haznedaroğlu İC   Göker H   Kosar A   Koçoğlu H   Büyükaşik Y   Sayinalp N   Kirazli Ş  

The Journal of International Medical Research, Vol. 30, Iss. 1, 2002-01 ,pp. : 52-55

Field House Publishing

Access to resources Recommend Favorite